Hester Biosciences logo

Hester Biosciences Q1 results, quarter to Jun 2026

NSE: HESTERBIOBSE: 524669Pharmaceuticals & BiotechnologySmall Cap

Hester Biosciences Limited · Face value ₹10 · Listed Oct 1994 on BSE, Mar 2015 on NSE
Last close ₹2,307.60up ₹63.90 (2.85%)BSE ₹2,306.60

Share price at the NSE close on 29 Oct 2026. Previous close ₹2,243.70.

29 Oct: open ₹2,243.70, high ₹2,333.10, low ₹2,223.00

52-week range of traded prices to 29 Oct 2026
₹1,239.30Low, 30 Mar 2026₹2,683.60High, 30 Jul 2026
Market cap
₹1,963 Cr1,322nd largest listed
P/E
14.42
P/E without one-offs
40.99
P/B
5.45
Dividend yield
0.48%
ROE
40.4%
ROE without one-offs
14.2%
ROCE
11.7%
Debt to equity
0.51
Volume, NSE
4,09656.3% delivered

Hester Biosciences filed its Q1 results for the quarter to Jun 2026 on 30 Jul 2026 at 11:54 am, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.Hester Biosciences annual results and balance sheet

Revenue
₹77 Cr−8.2% on a year ago · −22.8% on the quarter before
Operating profit
₹23 Cr−0.2% on a year ago · −33.7% on the quarter before
Net profit
₹97 Cr+459.3% on a year ago · +484.6% on the quarter before
Earnings per share
₹113.71+459.3% on a year ago · +484.6% on the quarter before
Operating margin
29.5%
Net margin
125.2%

From revenue to net profit, ₹ crore

  1. Revenue77
  2. Materials and goods−17
  3. Employee costs−15
  4. Other expenses−23
  5. Operating profit23
  6. Depreciation−7.0
  7. Other income+1.6
  8. One-off items+85
  9. Finance costs−3.1
  10. Profit before tax100
  11. Tax−5.0
  12. Joint ventures+2.0
  13. Net profit97

Hester Biosciences results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
704.0Sep 23674.0Dec 23796.4Mar 24827.5Jun 24848.4Sep 246311Dec 24821.5Mar 258417Jun 257114Sep 25779.3Dec 2510017Mar 267797Jun 26
Peak revenue ₹100 Cr, quarter to Mar 2026; lowest ₹63 Cr, quarter to Dec 2024

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
125.2%1.9%18.8%15.2%20.1%21.5%22.9%8.0%23.4%27.1%16.5%23.0%34.3%29.5%5.7%6.0%8.1%9.1%10.0%18.0%1.9%20.6%20.2%12.0%16.5%125.2%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Filed 28 OctDec 2021Q3Filed 31 JanMar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Sep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Filed 30 JanMar 2025Q4Filed 9 MayJun 2025Q1Sep 2025Q2Dec 2025Q3Filed 30 JanMar 2026Q4Jun 2026Q1Filed 30 Jul
Revenue from operations63565651737567887067798284638284717710077
4541464360565673575763656558636159606654
Materials and goods bought1613151421202034202122232520212219211917
Employee costs1111121215151416161616161616141516161615
Other expenses1817181724222123212126252422282424233023
Operating profit before depreciation18151071319121413101618195192312183423
Operating margin28.0%27.0%18.3%14.7%17.4%25.0%17.3%16.3%18.8%15.2%20.1%21.5%22.9%8.0%23.4%27.1%16.5%23.0%34.3%29.5%
Depreciation and amortisation35555555444444444467
Other income13734431414128−72101−32
Finance costs1122241382756−4622253
Profit before one-off items and tax151211410148855910111221915122014
One-off items000000000000000000385
Profit before tax1512114101488559101112219151223100
43224432323332233495
Tax rate26.7%28.7%21.1%48.9%37.8%27.4%33.3%29.2%52.2%46.0%37.0%31.9%31.9%15.8%90.5%15.1%18.2%34.5%36.8%5.0%
Share of profit of joint ventures and associates––021201210111112122
118947126744678112171491797
Other comprehensive income00111000−10100000−10−10
Total comprehensive income1181047125634889111171391696
Net margin17.8%15.0%16.0%7.0%9.0%16.2%8.5%7.6%5.7%6.0%8.1%9.1%10.0%18.0%1.9%20.6%20.2%12.0%16.5%125.2%
Net margin without joint ventures and associates––15.2%3.9%8.3%13.6%8.0%6.1%3.5%4.2%7.5%8.1%8.9%16.5%0.3%19.3%17.2%10.3%14.7%122.6%
Earnings per share₹13.08₹9.79₹10.59₹4.19₹7.77₹14.29₹6.72₹7.89₹4.75₹4.73₹7.52₹8.80₹9.86₹13.41₹1.82₹20.33₹16.85₹10.94₹19.45₹113.71
Earnings per share in rupees, restated for later splits and bonuses.

Segment results by quarter

Consolidated, ₹ crore, quarters to Jun 2026.Hester Biosciences segment results by year

  • Poultry Healthcare

    Revenue, ₹ crore
    Profit, ₹ crore
  • Animal Healthcare

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue of all businesses7067798284638284717710077
Company revenue, as in its results7067798284638284717710077
Revenue373545414138484248516562
Revenue growth5.2%10.6%21.5%40.9%11.4%8.7%6.7%2.0%17.6%35.5%36.0%47.5%
Profit54866510914122324
Profit growth−42.1%−2.0%29.2%129.9%35.8%29.1%36.1%65.8%116.5%150.4%124.6%163.4%
Margin12.5%10.9%17.0%13.5%15.3%12.9%21.6%21.9%28.2%23.9%35.7%39.1%
Assets239234245244248252261244258267123125
Liabilities20151816141717141320169
Capital employed220219228228233235244230245248108116
Revenue343235414325344223263515
0000000–––––
Profit is before tax and finance costs, the way companies report their segments.